Mahreen Ameen

2.5k total citations
48 papers, 1.4k citations indexed

About

Mahreen Ameen is a scholar working on Dermatology, Epidemiology and Immunology and Allergy. According to data from OpenAlex, Mahreen Ameen has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Dermatology, 17 papers in Epidemiology and 10 papers in Immunology and Allergy. Recurrent topics in Mahreen Ameen's work include Dermatology and Skin Diseases (13 papers), Fungal Infections and Studies (10 papers) and Asthma and respiratory diseases (9 papers). Mahreen Ameen is often cited by papers focused on Dermatology and Skin Diseases (13 papers), Fungal Infections and Studies (10 papers) and Asthma and respiratory diseases (9 papers). Mahreen Ameen collaborates with scholars based in United Kingdom, United States and Canada. Mahreen Ameen's co-authors include Roberto Arenas, Juliet N. Barker, Richard C. Trembath, A. David Burden, Francesca Capon, David M. Tillman, Michael H. Allen, A.C. Chu, C.A. HOLDEN and Sinésio Talhari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Human Molecular Genetics and The Lancet Infectious Diseases.

In The Last Decade

Mahreen Ameen

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahreen Ameen United Kingdom 19 685 320 286 244 224 48 1.4k
Satoshi Dekio Japan 19 301 0.4× 88 0.3× 245 0.9× 187 0.8× 128 0.6× 98 1.2k
Hill Gaston United Kingdom 22 349 0.5× 192 0.6× 89 0.3× 217 0.9× 721 3.2× 38 1.5k
Shigeo Nonaka Japan 18 448 0.7× 98 0.3× 151 0.5× 81 0.3× 78 0.3× 127 1.2k
Edgar B. Smith United States 19 379 0.6× 256 0.8× 332 1.2× 143 0.6× 75 0.3× 64 891
Catharina Johansson Sweden 23 515 0.8× 91 0.3× 736 2.6× 111 0.5× 395 1.8× 46 1.6k
Harvey Blank United States 22 701 1.0× 297 0.9× 335 1.2× 174 0.7× 81 0.4× 56 1.4k
Jackie C. Timans France 9 271 0.4× 210 0.7× 116 0.4× 86 0.4× 1.6k 7.0× 10 2.2k
Cécile Caubet France 19 96 0.1× 292 0.9× 301 1.1× 84 0.3× 139 0.6× 30 1.5k
Ivy M. Dambuza United Kingdom 17 483 0.7× 54 0.2× 69 0.2× 438 1.8× 1.1k 5.0× 33 2.0k
Christoph Kalis Germany 16 301 0.4× 32 0.1× 241 0.8× 100 0.4× 1.1k 4.9× 18 1.9k

Countries citing papers authored by Mahreen Ameen

Since Specialization
Citations

This map shows the geographic impact of Mahreen Ameen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahreen Ameen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahreen Ameen more than expected).

Fields of papers citing papers by Mahreen Ameen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahreen Ameen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahreen Ameen. The network helps show where Mahreen Ameen may publish in the future.

Co-authorship network of co-authors of Mahreen Ameen

This figure shows the co-authorship network connecting the top 25 collaborators of Mahreen Ameen. A scholar is included among the top collaborators of Mahreen Ameen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahreen Ameen. Mahreen Ameen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guttman‐Yassky, Emma, et al.. (2025). 63485 Efficacy of Abrocitinib in Patients Based on Prior Biologic Treatment History: A Post Hoc Analysis of JADE MONO-1, JADE MONO-2, and JADE REGIMEN. Journal of the American Academy of Dermatology. 93(3). AB190–AB190.
2.
3.
Ameen, Mahreen, et al.. (2024). Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis. Acta Dermato Venereologica. 104. adv24339–adv24339. 3 indexed citations
4.
Gooderham, Melinda, Michael R. Ardern‐Jones, Emma Guttman‐Yassky, et al.. (2023). Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials. SHILAP Revista de lepidopterología. 2(4). 753–763. 1 indexed citations
5.
Varghese, Nimmy, et al.. (2023). A review on recent pharmacological screening models to evaluate Parkinson’s disease. Annals of Phytomedicine An International Journal. 12(1). 2 indexed citations
6.
Ameen, Mahreen, et al.. (2023). Canalicular obstruction associated with dupilumab. International Ophthalmology. 43(12). 4791–4795. 1 indexed citations
7.
Ameen, Mahreen, et al.. (2021). Perception and Experience of Biologic Therapy in Atopic Dermatitis: A Qualitative Focus Group Study of Physicians and Patients in Europe and Canada. Dermatology and Therapy. 11(6). 2159–2177. 6 indexed citations
8.
Ameen, Mahreen, Saby George, Catherine Harwood, et al.. (2018). PSS44 - AN EVALUATION OF THE CURRENT TREATMENT PATHWAYS AND ASSOCIATED NHS RESOURCE USE FOR THE MANAGEMENT OF UNCONTROLLED MODERATE-TO-SEVERE ATOPIC DERMATITIS IN SECONDARY CARE. Value in Health. 21. S430–S430. 1 indexed citations
9.
Ameen, Mahreen, et al.. (2011). Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy. International Journal of Dermatology. 50(4). 443–445. 6 indexed citations
10.
Ameen, Mahreen. (2010). Cutaneous Markers of HIV Infection and Progression. Current HIV Research. 8(6). 450–455. 8 indexed citations
11.
Asz‐Sigall, Daniel, Marí­a Elisa Vega-Memije, Claudia Ramírez‐Rentería, et al.. (2010). HLA‐DR6 association confers increased resistance to T. rubrum onychomycosis in Mexican Mestizos. International Journal of Dermatology. 49(12). 1406–1409. 24 indexed citations
12.
Ameen, Mahreen. (2010). Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management. Expert Opinion on Pharmacotherapy. 11(4). 557–569. 20 indexed citations
13.
Ameen, Mahreen. (2010). Epidemiology of superficial fungal infections. Clinics in Dermatology. 28(2). 197–201. 324 indexed citations
14.
Ameen, Mahreen. (2010). Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clinical and Experimental Dermatology. 35(7). 699–705. 97 indexed citations
15.
Ameen, Mahreen & Roberto Arenas. (2008). Developments in the management of mycetomas. Clinical and Experimental Dermatology. 34(1). 1–7. 47 indexed citations
16.
Ameen, Mahreen, et al.. (2006). Acquired reactive perforating collagenosis: four patients with a giant variant treated with allopurinol. British Journal of Dermatology. 154(4). 759–762. 49 indexed citations
17.
Allen, M H, Kati Asumalahti, Mahreen Ameen, et al.. (2002). Genetic analysis of PSORS1 single nucleotide polymorphisms in guttate psoriasis and palmoplantar pustulosis.. British Journal of Dermatology. 147(4). 1 indexed citations
18.
Ameen, Mahreen, et al.. (2001). Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.. British Journal of Dermatology. 145(3). 476–479. 49 indexed citations
19.
Ameen, Mahreen, et al.. (2001). Pneumonitis complicating methotrexate therapy for pustular psoriasis. Journal of the European Academy of Dermatology and Venereology. 15(3). 247–249. 11 indexed citations
20.
Ameen, Mahreen, Supriya Chopra, A. Darvay, K. Acland, & A.C. Chu. (2001). Erythema gyratum repens and acquired ichthyosis associated with transitional cell carcinoma of the kidney. Clinical and Experimental Dermatology. 26(6). 510–512. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Dekio Breakdown of academic impact, for papers by Hill Gaston Breakdown of academic impact, for papers by Shigeo Nonaka Breakdown of academic impact, for papers by Edgar B. Smith Breakdown of academic impact, for papers by Catharina Johansson Breakdown of academic impact, for papers by Harvey Blank Breakdown of academic impact, for papers by Jackie C. Timans Breakdown of academic impact, for papers by Cécile Caubet Breakdown of academic impact, for papers by Ivy M. Dambuza Breakdown of academic impact, for papers by Christoph Kalis
Rankless by CCL
2026